Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,274) with videos related to
Page
of 128
Sort By:
JAMA
|
October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis
Stephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Nature Communications
|
December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma
Julia Paczkowska, Ming Tang, Kyle T Wright, et al.
American Journal of Human Genetics
|
August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings
Kathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
BMC Nephrology
|
February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes
Srinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
Archives of Internal Medicine
|
January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Journal of the American Society of Nephrology : JASN
|
August 13, 2016
BP Control and Long-Term Risk of ESRD and Mortality
Elaine Ku, Jennifer Gassman, Lawrence J Appel, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
Frans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Journal of Medicinal Chemistry
|
September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
JAMA Neurology
|
March 7, 2022
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial
Sudipto Dolui, John A Detre, Sarah A Gaussoin, et al.
Blood
|
June 11, 2021
Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome
Sangmoon Lee, Chang Hoon Shin, Jawon Lee, et al.
Page
of 128
Search research articles
Search
Showing results (1011-1020 of 1,274) with videos related to
Sort By:
Page
of 128
JAMA
|
October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis
Stephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.
Nature Communications
|
December 31, 2024
Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma
Julia Paczkowska, Ming Tang, Kyle T Wright, et al.
American Journal of Human Genetics
|
August 31, 2023
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings
Kathryn A McGurk, Xiaolei Zhang, Pantazis Theotokis, et al.
BMC Nephrology
|
February 25, 2021
Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes
Srinivasan Beddhu, Robert E Boucher, Jie Sun, et al.
Archives of Internal Medicine
|
January 30, 2008
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Jackson T Wright, Sonja Harris-Haywood, Sara Pressel, et al.
Journal of the American Society of Nephrology : JASN
|
August 13, 2016
BP Control and Long-Term Risk of ESRD and Mortality
Elaine Ku, Jennifer Gassman, Lawrence J Appel, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial
Frans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.
Journal of Medicinal Chemistry
|
September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
JAMA Neurology
|
March 7, 2022
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial
Sudipto Dolui, John A Detre, Sarah A Gaussoin, et al.
Blood
|
June 11, 2021
Somatic uniparental disomy mitigates the most damaging EFL1 allele combination in Shwachman-Diamond syndrome
Sangmoon Lee, Chang Hoon Shin, Jawon Lee, et al.
Page
of 128